THE CLINICAL IMPLICATION OF THE ACTIVATION OF NF-κB SIGNALING PATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA: PRE- AND POST-RITUXIMAB ERA

被引：0
|
作者：
Lee, L. [1 ]
Liu, J. H. [2 ]
Tzeng, C. H. [2 ]
Gau, J. P. [2 ]
Chen, P. M. [2 ]
Chiou, T. J. [2 ]
机构：
[1] Vet Gen Hosp Taipei, Taoyuan Branch, Hematol Oncol, Taipei, Taiwan
[2] Vet Gen Hosp Taipei, Hematol Oncol, Taipei, Taiwan
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E975
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [21] CLINICAL SIGNIFICANCE OF BIOMARKERS OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Niitsu, N.
    Hayama, M.
    Hagiwara, Y.
    Tanae, K.
    Kohri, M.
    Takahashi, N.
    ANNALS OF ONCOLOGY, 2011, 22 : 154 - 154
  • [22] Prognostication of diffuse large B-cell lymphoma in the rituximab era
    Ninan, Mary J.
    Wadhwa, Punit D.
    Gupta, Pankaj
    LEUKEMIA & LYMPHOMA, 2011, 52 (03) : 360 - 373
  • [23] Primary refractory diffuse large B cell lymphoma in the rituximab era
    Sarkozy, Clementine
    Coiffier, Bertrand
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 377 - 383
  • [24] Diffuse large B cell lymphoma: prognostic factors in the rituximab era
    Guevara Arismendy, Natalia Maria
    Jaramillo Arbelaez, Patricia Elena
    Gaviria Jaramillo, Lina Maria
    IATREIA, 2013, 26 (03) : 302 - 312
  • [25] TRAF3 Loss Drives Alternative NF-κB Pathway Activation in Diffuse Large B-Cell Lymphoma
    Li, Michael Y.
    Chong, Lauren C.
    Chavez, Elizabeth
    Woolcock, Bruce W.
    Telenius, Adele
    Lam, Vivian
    Krystal, Gerald
    Scott, David W.
    Vigano, Elena
    Healy, Shannon
    Steidl, Christian
    BLOOD, 2020, 136
  • [26] RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
    Zhang, Mingzhi
    Xu-Monette, Zijun Y.
    Li, Ling
    Manyam, Ganiraju C.
    Visco, Carlo
    Tzankov, Alexandar
    Wang, Jing
    Montes-Moreno, Santiago
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Moller, Michael B.
    Parsons, Ben M.
    Winter, Jane N.
    Piris, Miguel A.
    Medeiros, L. Jeffrey
    Pham, Lan V.
    Young, Ken H.
    AGING-US, 2016, 8 (12): : 3321 - 3340
  • [27] NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
    Jayawant, Eleanor
    Pack, Arran
    Clark, Heather
    Kennedy, Emma
    Ghodke, Ankur
    Jones, John
    Pepper, Chris
    Pepper, Andrea
    Mitchell, Simon
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway
    Ramachandiran, Sampath
    Adon, Arsene
    Guo, Xiangxue
    Wang, Yi
    Wang, Huichen
    Chen, Zhengjia
    Kowalski, Jeanne
    Sunay, Ustun R.
    Young, Andrew N.
    Brown, Theresa
    Mar, Jessica C.
    Du, Yuhong
    Fu, Haian
    Mann, Karen P.
    Natkunam, Yasodha
    Boise, Lawrence H.
    Saavedra, Harold I.
    Lossos, Izidore S.
    Bernal-Mizrachi, Leon
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (10) : 2341 - 2351
  • [29] A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma
    Hongbo Wang
    Wei Wei
    Jing-Ping Zhang
    Zhihui Song
    Yangyang Li
    Wenming Xiao
    Yijun Liu
    Mu-Sheng Zeng
    Michael N. Petrus
    Craig J. Thomas
    Marshall E. Kadin
    Masao Nakagawa
    Thomas A. Waldmann
    Yibin Yang
    Leukemia, 2021, 35 : 1976 - 1989
  • [30] A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma
    Wang, Hongbo
    Wei, Wei
    Zhang, Jing-Ping
    Song, Zhihui
    Li, Yangyang
    Xiao, Wenming
    Liu, Yijun
    Zeng, Mu-Sheng
    Petrus, Michael N.
    Thomas, Craig J.
    Kadin, Marshall E.
    Nakagawa, Masao
    Waldmann, Thomas A.
    Yang, Yibin
    LEUKEMIA, 2021, 35 (07) : 1976 - 1989
12345